They say this finding, reported at the annual meeting of the American Association for Cancer Research (AACR), provides new evidence that breast cancer can arise from stem cells and that targeting this gene might provide a new way to treat cancers of the breast as well as other tumor types.
“This is the first time any role has been attributed to this gene, and it turns out to be one that is surprisingly powerful,” says the study’s lead author, Xiaoyang Wang, Ph.D., Postdoctoral Fellow at Georgetown’s Lombardi Comprehensive Cancer Center.
Specifically, Wang and the researchers show for the first time that this gene, Musashi1 (Msi1), switches on Wnt and Notch cell signaling. Both of these pathways help control stem cell growth, and are known to be critically important to the development of many cancers.
Msi1 was named after a famous 17th century Japanese swordsman, Miyamoto Musashi, by Japanese researcher Hideyuki Okano, Ph.D., who identified it in fruit flies in 1994. Okano currently collaborates with the Georgetown scientists.
Recent studies have shown Msi1 to be a marker of human stem cells in general because it has been found in human breast, colon, brain, skin, and other cells, says Robert Glazer, Ph.D., a professor of Oncology and Pharmacology and the study’s senior author.
So Glazer and Wang decided to probe the gene’s function. “Msi1 is known to be a marker of stem cells, but no one knows what it does. We wanted to see if it had a function in the mammary gland,” Glazer says.
They were especially interested in whether Msi1 is associated with cancer development because recent studies have suggested that stem cells may be the causative root of some cancers – a notion that is vigorously debated among cancer researchers.
“It is really critical to understand if stem cells are involved in cancer development because a lot of therapies used to treat cancer don’t target stem cells,” he says. “That may explain why tumors come back.”
In laboratory experiments, the scientists found that, in mammary cell development, Msi1 drives mammary cells along different lineages – in other words, it can decide what type of cell develops in the breast, be it muscle cells or cells that line milk ducts, etc.
In cancer, the Wnt and Notch pathways are often activated, and the researchers found that Msi1 is expressed in particularly aggressive tumors. The researchers then tested whether Msi1 regulates these pathways in mammary cells and found that it did.
The researchers then studied how Msi1 drives the Wnt and Notch pathways found that when Msi1 was over-expressed, there was an increased secretion of a growth factor known as proliferin, and reduced secretion of the Wnt pathway inhibitor, Dickkopf-3. Additionally, Msi1 programmed the expression of a number of genes that have a concerted effect on the cell cycle, Wang says.
“We believe that while Msi1 may contribute to cell proliferation, it is not the single gene that controls cancer development,” Glazer says.
“This work suggests, but does not prove, that stem cells drive breast cancer formation,” he says. “Msi1 might make a good therapeutic target, and we are currently testing ways to interfere with its function in cells to see if it disrupts cancer cell proliferation.”
Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University
How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy